营养药物干预阿尔茨海默病:从农场到药房
P M Chaithra1, B S Rakshith1, S Logesh1
1Department of Biotechnology & Bioinformatics, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.
营养药物通过向炎症和氧化应激,对阿尔茨海默氏症 (AD) 有希望. 通过先进的方法提高它们的传递和有效性,为AD缓解提供了一个可持续的途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,也是痴呆的主要原因,目前仅有有限的疾病修饰性治疗方法.
- 目前的AD疗法提供症状缓解,但不能阻止疾病的进展,需要探索替代策略.
- 来自自然来源的营养药物通过调节炎症,氧化应激和神经退行来对抗AD病理的多目标方法.
研究的目的:
- 探索营养保健品作为阿尔茨海默病治疗的替代治疗策略的潜力.
- 为了应对营养药物生物可用性和AD治疗有效性的挑战.
- 突出食品加工,配送方法和个性化营养方面的进步,以提高营养药的有效性.
主要方法:
- 审查现有的临床试验数据关于AD的营养药.
- 分析食品加工和配送系统的进步.
- 探索个性化的营养方法.
- 讨论涉及营养药的组合疗法.
主要成果:
- 营养药证明了与AD病理学相关的多目标机制.
- 临床试验表明,营养药物生物可用性和疗效存在挑战.
- 食品加工,配送和个性化营养方面的创新有可能克服这些限制.
- 组合疗法有望增强营养药的治疗效果.
结论:
- 营养药品为阿尔茨海默病的管理提供了一个有前途的途径,因为它们具有多重目标效应.
- 通过先进的输送系统和个性化的营养来克服生物可用性和有效性挑战至关重要.
- 将营养药物整合到组合疗法中,代表了从农场到药店可持续减轻AD的重要未来方向.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
相关概念视频
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Prodrugs
Prodrugs help overcome...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
